NKG2D-CAR-NK92 Cells Immunotherapy for Solid Tumors
NCT05528341
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Relapsed/Refractory Solid Tumors
Interventions
BIOLOGICAL:
NKG2D-CAR-NK92 cells
Sponsor
Henan Medical University